Olfactory function can be influenced by many factors and olfactory dysfunction is associated with several diseases. But even considering this, the causes of acquired olfactory dysfunction in children are not well understood. This review was conducted to gain an overview of the etiologies of acquired olfactory dysfunction in a pediatric population. Studies were identified using a predefined literature search, including studies if patients were ≤18 years of age and results of psychophysical olfactory testing were reported. A total of 44 articles met the inclusion criteria for this review and were included in the qualitative analysis. The influence of 6 disease groups on olfactory function in children was observed (otorhinolaryngology, traumatic brain injury, oncology, psychiatric diseases, environmental factors, and other diseases). The current literature is convincing that diseases in the otorhinolaryngology group and traumatic brain injury can lead to acquired olfactory dysfunction, whereas according to the current literature, the role of other influencing factors such as most psychiatric disorders remains uncertain. A number of diseases and circumstances affect olfactory function in children and may cause acquired olfactory dysfunction in this age group. Nevertheless, more research is needed to better understand the causes of acquired olfactory dysfunction in children. Future research should have the goal of early diagnosis and, if possible, early treatment of the condition to prevent a negative impact of olfactory dysfunction on children and adolescents.
Introduction
Our sense of smell is involved in many everyday situations. Not only is olfaction important for food intake, but it also plays a role in social communication and detection of warning signals (Stevenson 2010) . Smells are important for the mother-child bonding and even may influence our choice of partner (Havlicek and Roberts 2009 ). In addition, hazards, such as gas, fire, or spoiled food, can be detected with the sense of smell (Santos et al. 2004) . Large cohort studies have reported a reduced sense of smell in approximately 20% of an adult population and even 5% within this population are anosmic (Temmel et al. 2002; Brämerson et al. 2004; Landis et al. 2004 ). The prevalence of olfactory dysfunction increases with age (Doty et al. 1984a) . Although there are no data available about the prevalence of olfactory dysfunction in children, it is thought to be less frequent than in adults (Oozeer et al. 2011) . Olfactory dysfunction can either be acquired or due to genetic conditions. Previous work in adults has shown that the major causes of acquired olfactory dysfunction in adults are sinonasal, post-infectious, and traumatic brain injury (TBI) (Temmel et al. 2002; Damm et al. 2004) . In addition to these etiologies, it was shown that, for example, kidney disease and hypothyroidism can be associated with reduced olfactory function (Deniz et al. 2016; Koseoglu et al. 2017) and that up to 95% of patients with Parkinson's disease suffer from anosmia or hyposmia (Haehner et al. 2011) .
Although no study has addressed this issue in children and adolescents, it was shown that the above-mentioned everyday situations can be affected in adults with olfactory dysfunction. Adults with olfactory dysfunction experience more hazardous events such as food poisoning or failure to detect fire (Santos et al. 2004 ). Olfactory dysfunction also has an impact on the quality of life (Croy et al. 2014) . It leads to social insecurity (Croy et al. 2012; Bojanowski et al. 2013) and is even associated with depression (Croy et al. 2014; Croy and Hummel 2017) .
The treatment of olfactory dysfunction is dependent on its etiology. Although there is no treatment available for congenital anosmia, olfactory function due to sinonasal disease can be surgically improved (Philpott et al. 2008) . Topical and systemic steroids are used to treat post-infectious and post-traumatic associated olfactory dysfunction (Seo et al. 2009; Jiang et al. 2010) . In recent years, a method called "olfactory training" has been developed to improve olfactory dysfunction of several etiologies, including TBI, post-infectious, and Parkinson's disease (Haehner et al. 2013; Konstantinidis et al. 2013; Altundag et al. 2015) . These findings were obtained from adult populations.
Over the course of the last several decades, feasible tests for measuring olfactory function in a clinical setting have been developed, such as the University of Pennsylvania Smell Identification Test (UPSIT) or the "Sniffin' Sticks" test (Doty et al. 1984b; Hummel et al. 2007 ). Due to these developments, research regarding olfactory dysfunction and therefore the knowledge about the etiologies of acquired olfactory dysfunction increased. Whereas the etiologies of acquired olfactory dysfunction in adults are well described in the above-mentioned literature, the research about olfactory dysfunction in children focused on genetic conditions as part of congenital anosmia. People with congenital anosmia are born without a functioning sense of smell. Genetic conditions, which can be associated with congenital anosmia, are, for example, Kallmann syndrome (Ottaviano et al. 2015) , CHARGE syndrome (Chalouhi et al. 2005) , and congenital insensitivity to pain (Mansouri et al. 2014) . Little is known about acquired olfactory dysfunction in children and adolescents. What are the causes of acquired olfactory dysfunction in children and adolescents? It seems plausible that some of the etiologies of acquired olfactory dysfunction in adults may also be associated with a reduced sense of smell in children (e.g., TBI), while others like Parkinson's disease do not apply. The other senses-vision and hearing-are routinely examined in children to initiate early therapy and therefore optimizing the child's development, whereas the sense of smell is not routinely examined. This systematic review of the literature was conducted to bundle the knowledge about the causes of acquired olfactory dysfunction in children and adolescents with the aim to point out which patients could benefit from olfactory testing to initiate early therapy, if possible, and to provide education about olfactory dysfunction to minimize or prevent the negative consequences that might results from olfactory dysfunction.
Methods
The systematic review was conducted in December 2017 by the first author (V.A.S.) using the following databases: PubMed, Ovid Medline, and ISI Web of Science. No restrictions were placed on the date of publication. The following search criteria were applied: Ovid Medline: Smell (subject heading) AND adolescents OR child (subject heading) AND olfaction disorders (subject heading) OR dysfunction (keyword) OR disorder (keyword) OR hyposmia (keyword) OR anosmia (keyword), limit to English or German. ISI Web of Science: (TS = (("child*" or "children*" or "adolescent*") AND ("smell*" or "olfaction*" or "olfactory*") AND ("dysfunction*" or "disorder*" or "anosmia*" or "hyposmia*"))) AND LANGUAGE: (English OR German)
Publications were selected in 4 steps: 1) removal of duplicates, 2) publications were selected based on their title, 3) the abstracts of the selected publications were read, and 4) based on the abstract, the full text of selected publications was read.
Previous to the literature search, the following inclusion and exclusion criteria were defined for this review:
Inclusion criteria
• Age of reported population ≤18 years • Publication including patients • Psychophysical olfactory testing • Publication in English or German language
Exclusion criteria
• Inclusion criteria were not met • Review articles • Anosmia due to genetic disorders • Anosmia due to defects that are present at birth
The search of the databases resulted in a total of 1711 publications and 1284 articles remained after removal of duplicates. Based on their title, 520 articles were selected. Of these 520 articles, 281 were excluded based on the abstract. Therefore, the full text of 239 articles was read; 40 publications met the predefined criteria for this review. In addition, 4 publications were identified as citations in other publications meeting the review criteria. Therefore, 44 publications met the criteria and were eligible for the qualitative analysis of this review. For a flowchart, see Supplementary Material 1.
The focus of this review was on acquired olfactory dysfunction. Publications targeting anosmia due to genetic variations and defects or anomalies, which are present at birth, were not included in this review for the following reasons: 1) The pathomechanism of genetic olfactory dysfunction is different from acquired olfactory dysfunction. Children are born without a sense of smell, which is in most cases due to anatomical anomalies of the olfactory system; 2) there is no treatment available regarding the sense of smell in these conditions, whereas patients with acquired olfactory dysfunction might benefit from treatment; and 3) anomalies or defects, which are present at birth are often in association with genetic variations and a clear distinction of these 2 is difficult.
Results
A total of 44 articles met the criteria of this review and were further analyzed. The following 3 parameters of olfactory testing-olfactory sensitivity (odor detection), odor discrimination, and odor identification-were included in the analysis. These parameters have been proven to be feasible for the evaluation of olfactory function in a clinical setting. At least one of these 3 olfactory tests was reported in the studies included in the review. The age of patients ranged from 4 to 18 years. A total of 1523 patients were examined within these 44 studies. There was a large range of diseases, which potentially influence olfactory function in children and adolescents. Therefore, the publications were grouped in 6 categories: 1) otorhinolaryngology, 2) TBI, 3) oncology, 4) psychiatric diseases, 5) environmental factors, and 6) other diseases. Olfactory functions in children and adolescents are described in detail separately for these 6 categories in the following sections.
Otorhinolaryngology
This category includes 10 articles addressing 5 diseases belonging to otorhinolaryngology (adenoid hypertrophy, tracheotomy, allergic rhinitis, otitis media, and surgical intervention).
Four publications describe reduced olfactory function in patients with adenoid hypertrophy including 162 children (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) . All 4 studies were conducted as cohort studies, but with several limitations, to measure olfactory function in children with adenoid hypertrophy before and after surgical treatment. Olfactory function was measured by means of odor detection (Ghorbanian et al. 1983; Delank 1992) , odor discrimination (Delank 1992) , and odor identification (Konstantinidis et al. 2005; Altundag et al. 2014) . Measurements of nasal obstruction or adenoid hypertrophy were conducted, whereas the methods differed across the 4 studies. The patients' age ranged from 5 to 15 years and was similar across studies. All 4 studies reported reduced olfactory function in children with adenoid hypertrophy compared with a control group (Konstantinidis et al. 2005; Altundag et al. 2014) or with previously acquired normative data (Ghorbanian et al. 1983; Delank 1992) . In the majority of the studies, the degree of nasal obstruction or adenoid size negatively influenced olfactory function (Ghorbanian et al. 1983; Delank 1992; Altundag et al. 2014 ). Only Konstantinidis et al. (2005) observed no correlation between olfactory function and adenoid hypertrophy stages measured by means of X-ray. A total of 118 children underwent adenoidectomy and olfactory function was assessed 2-28 months after surgery. In all studies, an improvement of olfactory function after surgery was observed (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) , reaching the olfactory performance of healthy controls (Delank 1992; Altundag et al. 2014) . Neither olfactory function nor nasal obstruction changed in a follow-up of untreated children with adenoid hypertrophy (n = 16) (Ghorbanian et al. 1983) . These 4 studies report reduced olfactory function in children with adenoid hypertrophy. The authors explain the reduction of olfactory ability with an obstruction of the nasal airways and therefore with a reduced airflow reaching the olfactory cleft (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) . The finding that olfactory function improved after adenoidectomy supports this explanation. In addition, nasal inflammation might contribute to a decreased olfactory function (Delank 1992; Konstantinidis et al. 2005) . Based on the study design and number of included patients, the 4 studies have an equal level of evidence.
Two case-control studies, including 27 patients, observed olfactory function in patients with tracheotomy (Rothschild et al. 1995; Kennedy et al. 2016) . Both studies used an odor identification test to measure olfactory function. Rothschild et al. (1995) reported reduced odor identification ability in patients after tracheotomy in children and adolescents aged 4-16 years. In line with these findings, Kennedy et al. (2016) reported reduced odor identification ability in 6 children with tracheotomy. In addition, olfactory dysfunction persisted in decannulated patients-after restoration of the normal airways-with 16 years being the longest tested interval (Kennedy et al. 2016) . The authors attribute the effect of tracheotomy on olfactory function to a changed airflow in the upper airways and therefore a changed odorant transport to the olfactory receptors (Rothschild et al. 1995; Kennedy et al. 2016 ). In addition, reduced "olfactory learning" is assumed because olfactory function does not fully recover after decannulation (restoration of normal airways) (Kennedy et al. 2016 ). Although results from both studies support each other, it has to be mentioned that the number of patients included in theses case-control studies was very small.
Odor detection and nasal patency were measured in a case series of 12 children who underwent palate expansion (Ottaviano et al. 2014 ). An increase in olfactory sensitivity was observed in 2 followup appointments 20 days and 6 months after surgical palate expansion. The increase in olfactory sensitivity was in association with an increase in nasal patency (Ottaviano et al. 2014 ). This case series does not state whether children had a reduced sense of smell before surgical intervention but only report the increase of olfactory function in association with the intervention. Only 12 children and no control group were included in this case series.
Two studies addressed the issue of allergic rhinitis in children-1 case series and 1 case-control study (Tansuker et al. 2014; Kutlug et al. 2016) . All 3 subtests of olfactory function were measured by Tansuker et al., whereas Kutlug et al. assessed the olfactory discrimination and odor identification ability. In Tansuker et al.'s study, only 1 child, a 13-year-old girl, was included in the case series of 12 patients with allergic rhinitis. This girl had a normal olfactory function. After systemic immunotherapy, the odor identification ability increased, whereas odor detection and odor discrimination were unchanged (Tansuker et al. 2014 ). Kutlug et al. conducted a case-control study including 77 children with allergic rhinitis and 45 healthy children. No difference between these 2 groups was observed in regard to olfactory discrimination and odor identification scores. Only a subgroup of patients, with a duration of allergic rhinitis greater than 3 years, exhibit a reduced odor discrimination ability (Kutlug et al. 2016) . No correlation between olfactory function and blood IgE levels was observed (Kutlug et al. 2016) . The alteration of olfactory function was thought to be caused by inflammation of the nasal and olfactory mucosa leading to damage of the olfactory epithelium (Kutlug et al. 2016 ). The results of Kutlug et al. are of stronger evidence because only 1 child was included in the study by Tansuker et al.
A case-control study showed no alteration of olfactory function in 220 children with recurring otitis media (Armstrong et al. 2008 ). The authors mentioned that a potential reduction of olfactory function might have been missed because a regeneration of olfactory function might have occurred in the interval between otitis media infection and olfactory assessment (Armstrong et al. 2008) .
According to the current literature, several diseases belonging to otorhinolaryngology might affect olfactory function in children. Although the number of studies and examined pediatric patients is rather small, an altered airflow in the nasal cavity might be associated with a reduced sense of smell with the strongest evidence in patients with adenoid hypertrophy followed by tracheotomy (Ghorbanian et al. 1983; Delank 1992; Rothschild et al. 1995; Konstantinidis et al. 2005; Altundag et al. 2014; Kennedy et al. 2016) . Chronic or recurrent nasal inflammation might damage the olfactory mucosa in long-lasting allergic rhinitis (Kutlug et al. 2016) . No randomized control study was conducted regarding the therapy of olfactory dysfunction in these etiologies. Adenoidectomy has been shown to be effective in restoring olfactory function in the 4 reported studies (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) .
Traumatic brain injury
A total of 6 studies, ranging from case reports to cohort studies, including 229 pediatric patients after TBI, met the inclusion criteria for this systematic review. Two studies by Bakker et al. (2016a Bakker et al. ( , 2016b used the same patient population. The patients are therefore only counted once in this review. The severity of TBI can be graded based on the Glasgow Coma Scale into mild-moderate-severe. Olfactory function was measured by means of odor detection, odor discrimination (Schriever et al. 2014) , and odor identification (Roberts and Simcox 1996; Sandford et al. 2006; Swann et al. 2006; Bakker et al. 2016a Bakker et al. , 2016b ). An association between TBI and reduced sense of smell was observed in all 6 studies with olfactory function being only slightly reduced (Schriever et al. 2014 ) to 75% of the patient population suffering from olfactory dysfunction (Roberts and Simcox 1996) . Several factors were identified as risk factors for developing olfactory dysfunction after TBI. The severity of TBI significantly influenced the likelihood of developing olfactory dysfunction after TBI. Roberts and Simcox (1996) reported olfactory dysfunction in 45% of patients after mild TBI and 75% of patients after severe TBI. This was supported by Bakker et al. (2016a) , who reported a greater reduction of olfactory function after severe TBI compared with mild TBI. Sandford et al. (2006) could only observe reduced olfactory function in patients after severe TBI, whereas Schriever et al. (2014) reported reduced olfactory sensitivity in children after mild TBI. Other risk factors for developing olfactory dysfunction after TBI include intracranial injury (Sandford et al. 2006) , pathological computerized tomography scan of the head (Sandford et al. 2006) , post-traumatic amnesia (Bakker et al. 2016a) , and loss of consciousness (Sandford et al. 2006) . Two studies were conducted in a longitudinal design (Schriever et al. 2014; Bakker et al. 2016b ). Although Bakker et al. (2016b) observed a significant increase in olfactory function in most of their patients in a followup of 18 months after the initial testing, Schriever et al. (2014) did not observe an increase in olfactory function 12 months after TBI. Regarding the neurological outcome parameters, it was observed in 1 study that children with olfactory dysfunction after TBI scored lower on executive tests compared with children after TBI without olfactory dysfunction (Roberts and Simcox 1996) . This is contradicted by the findings of Bakker et al. (2017) who did not observe a significant relationship between executive function and olfactory dysfunction after TBI.
None of the 6 studies addressed the pathophysiology of olfactory dysfunction after TBI in their study design. Shearing of the olfactory nerve fibers and frontal brain damage and hemorrhages within the olfactory brain regions and olfactory bulb were suggested as underlying mechanisms in all studies (Roberts and Simcox 1996; Sandford et al. 2006; Swann et al. 2006; Schriever et al. 2014; Bakker et al. 2016a Bakker et al. , 2016b . Bakker et al. (2016b) speculated a dual process, whereas olfactory function would recover after minor frontal brain damage but not after shearing of the olfactory nerve fibers.
Discrepancies of results across the 6 studies addressing olfactory dysfunction after TBI in pediatric population might result from different study designs, time of olfactory assessment after TBI, and olfactory tests being used. Only 3 studies used a validated olfactory test (Sandford et al. 2006; Schriever et al. 2014; Bakker et al. 2016a) . Using the study design as a criterion, cohort studies by Schriever et al. (2014) and Bakker et al. (2016b) have the highest validity. Overall, an association between olfactory dysfunction and TBI in a pediatric population can be assumed. Further research is necessary, with a focus on risk factors for developing olfactory dysfunction after TBI.
Oncology
Only 1 study was conducted addressing diseases belonging to the category of "oncology." The influence of oncological therapy on olfactory function, but not the effect of the underlying diseases, was examined. Cohen et al. (2012) studied odor identification ability using a cross-sectional study design in patients after blood and marrow transplant patients. A total of 10 patients between the ages of 10 and 15 years were included in the study. Olfactory identification ability was measured before conditioning therapy and 1 and 2 months after blood or marrow transplant. One-third of children had a reduced sense of smell 1 month after blood or marrow transplant. In a follow-up, 1 month later, all patients had regained normal olfactory function. The authors assume a damaging effect of chemotherapy (as conditioning before blood or marrow transplant) to the olfactory epithelium and the olfactory receptor neurons, with a fast recovery in pediatric patients (Cohen et al. 2012) .
Psychiatric diseases
The diseases that are grouped in this category are heterogeneous and include the following: anorexia nervosa and other eating disorders, attention-deficit hyperactivity disorder (ADHD), autism spectrum disorders, psychosis, and aggression.
In 3 case-control studies including 139 patients, aged 9-18 years, with eating disorders, olfactory function was measured (Roessner et al. 2005; Schecklmann et al. 2012; Stein et al. 2012) . Patients with only anorexia nervosa were included in 2 studies (Roessner et al. 2005; Schecklmann et al. 2012 ), whereas Stein et al. (2012) studied adolescents with anorexia nervosa-restrictive and binge-eating and bulimia nervosa. Olfactory sensitivity and odor discrimination ability were assessed in all 3 studies (Roessner et al. 2005; Schecklmann et al. 2012; Stein et al. 2012 ) and odor identification ability was additionally measured by Roessner et al. (2005) and Schecklmann et al. (2012) . Roessner et al. (2005) observed reduced odor detection and odor discrimination ability but unchanged odor identification scores in patients with anorexia nervosa. In the population examined by Schecklmann et al. (2012) , none of the 3 olfactory tests-odor detection, odor discrimination, and odor identification-were altered. In a subgroup of patients with anorexia nervosa without comorbidities (e.g., ADHD), a superior olfactory function, by means of odor identification testing, was observed (Schecklmann et al. 2012 ). In line with this finding, increased olfactory sensitivity as well as a superior odor discrimination ability were reported by Stein et al. (2012) in patients with eating disorders. No difference between the types of eating disorders in regard to olfactory function was observed (Stein et al. 2012) . Addressing influencing factors, a positive correlation of body mass index (BMI) and olfactory test scores was reported by Roessner et al. (2005) , whereas no such correlation could be observed by Stein et al. (2012) . But Stein et al. (2012) observed a positive correlation between olfactory function and eating disorderrelated obsessionality. The results of the 3 studies targeting olfactory function in patients with eating disorders are not conclusive. An altered peripheral olfactory function due to changes in metabolism caused by low body weight was argued by Roessner et al. (2005) to be responsible for the decreased olfactory function in their study population. In contrast, the superior olfactory performance in patients with eating disorders is explained by differing central odor processing, especially by increased responses in amygdala and hippocampus (Schecklmann et al. 2012; Stein et al. 2012) . Although more patients were examined by Stein et al. (2012) , it has to be kept in mind that 4 different eating disorder entities were included in this study. The level of evidence is therefore comparable among the 3 studies. Based on these 3 publications, the influence of eating disorders on olfactory function is not clear in pediatric patients and needs to be addressed further.
In a total of 5 case-control studies, olfactory function was measured in patients with ADHD. The studies included 179 patients ranging from 5 to 17 years of age (Karsz et al. 2008; Romanos et al. 2008; Schecklmann et al. 2011; Ghanizadeh et al. 2012; Lorenzen et al. 2016) . Olfactory function was measured by means of odor identification (Karsz et al. 2008; Ghanizadeh et al. 2012) , odor detection (Ghanizadeh et al. 2012; Lorenzen et al. 2016) , and all 3 tests of olfactory function (odor detection, odor discrimination, and odor identification) (Romanos et al. 2008; Schecklmann et al. 2011) . The results of these 5 studies are contradictory regarding the influence of ADHD on olfactory function in children. A reduced olfactory function by means of reduced odor identification and odor detection was observed (Karsz et al. 2008; Ghanizadeh et al. 2012) . In contrast, increased olfactory function was reported in other studies (Romanos et al. 2008; Schecklmann et al. 2011; Lorenzen et al. 2016) . Patients with ADHD showed a superior olfactory sensitivity (Romanos et al. 2008; Lorenzen et al. 2016 ) as well as odor discrimination abilities (Schecklmann et al. 2011 ) compared with healthy children. No difference in odor identification ability between patients and controls was observed in the later studies (Romanos et al. 2008; Schecklmann et al. 2011) .
Methylphenidate as a first-line medication for patients with ADHD seems to affect olfactory function in patients with ADHD. Three studies addressed this topic. No difference in odor identification ability in medicated and unmedicated children with ADHD was reported by Karsz et al. (2008) , whereas Romanos et al. (2008) only observed increased olfactory sensitivity in ADHD patients without methylphenidate medication. Schecklmann et al. (2011) , who reported superior olfactory discrimination scores in unmedicated ADHD patients, support the later finding. Due to the finding that ADHD patients treated with methylphenidate scored within the range of healthy control children, the authors concluded that the dopaminergic system is involved in the increased olfactory ability in patients with ADHD (Romanos et al. 2008; Schecklmann et al. 2011) . This is supported by imaging studies that show altered central odor processing, especially in temporal dopaminergic brain regions (Schecklmann et al. 2011 ) as well as increased connectivity of dopaminergic brain areas (Lorenzen et al. 2016) . The authors of the 2 studies reporting reduced olfactory function explain their findings with changes in neuronal processing, especially in the orbito-frontal cortex (Karsz et al. 2008; Ghanizadeh et al. 2012) . Discrepancies between the reported findings might result from differences in patient population-especially with regard to medication. Although, in about half of the patient group, a reduced olfactory function was described (Karsz et al. 2008; Ghanizadeh et al. 2012) , the 3 studies reporting a superior olfactory function in children with ADHD described their patient population in greater detail and additionally supported their findings by studied underlying neuronal mechanisms (Schecklmann et al. 2011; Lorenzen et al. 2016) .
Olfactory function in patients with autism spectrum disorders was assessed in 7 case-control studies, including 185 patients between ages 5 and 18 years. Parma et al. and Dudova et al. conducted 2 studies each, using the same patient population (Dudova et al. 2011; Dudova and Hrdlicka 2013; Parma et al. 2013 Parma et al. , 2014 . The patients of these studies are therefore only counted once. Odor identification testing was conducted in the majority of studies (Bennetto et al. 2007; Brewer et al. 2008; Dudova et al. 2011; May et al. 2011; Parma et al. 2014; Muratori et al. 2017) . In addition, 3 studies included odor detection testing (Dudova et al. 2011; Kumazaki et al. 2016; Muratori et al. 2017 ) and odor discrimination ability was assessed in 1 study (Muratori et al. 2017) . A reduced olfactory function was reported in all but 1 study. Only Brewer et al. (2008) did not observe a difference in odor identification testing between patients with autism spectrum disorders and healthy control children. The different findings compared to other studies were explained by a younger patient population examined by Brewer et al. (2008) . Other studies reported reduced odor identification ability in patients with autism spectrum disorders (Bennetto et al. 2007; May et al. 2011; Parma et al. 2014; Muratori et al. 2017 ) as well as a lower olfactory sensitivity (Dudova et al. 2011; Kumazaki et al. 2016; Muratori et al. 2017 ). The age of the patients was found to be of importance. Brewer et al. (2008) observed a negative correlation between the age of patients and odor identification ability-formulating the statement "grow into deficit"-which is in contrast to the otherwise observed increase in odor identification performance from childhood to adolescence (Doty et al. 1984a; Cameron and Doty 2013) . This was supported by Dudova et al. (2011) , who reported normal odor identification ability in young children, and May et al. (2011) , reporting altered olfactory development in children with autism spectrum disorders in a longitudinal study design. Most patients included in these studies were either children with Asperger's syndrome or high-functioning autism. May et al. (2011) found reduced odor identification ability in patients with high-functioning autism, whereas patients with Asperger's syndrome had a normal olfactory function. The authors therefore suggest differences in the neurobiological correlates regarding olfactory function in the 2 types of autism spectrum disorders (May et al. 2011) . Although Dudova and Hrdlicka (2013) did not observe a correlation between olfactory function and disease severity, a positive correlation between social competence by means of ability of maintaining a reciprocal conversation and odor identification ability was reported (Bennetto et al. 2007 ). Most authors speculate that the reduced olfactory function is caused by alterations in the neuronal function within the orbitofrontal cortex (Bennetto et al. 2007; Brewer et al. 2008; Dudova et al. 2011; May et al. 2011; Parma et al. 2014; Kumazaki et al. 2016) or the amygdala (Muratori et al. 2017 ). This is supported by previous studies reporting changes in orbito-frontal cortex function in patients with autism spectrum disorders (Bennetto et al. 2007) . It is worth mentioning that patients in studies published before 2013 were diagnosed based on DSM-4 criteria (Diagnostic and Statistical Manual of Mental Disorders), and DSM-5 was used in studies published after 2013. Although all studies used standard diagnostic tools, such as the ADI-R (Autism Diagnostic Interview-Revised), there are differences in the 2 DSM versions, for example, Asperger's syndrome is no longer defined as a separate diagnosis but is listed under autism spectrum disorders.
Only 1 observational study was conducted to measure olfactory function in patients with psychosis. Corcoran et al. (2005) examined 26 patients aged 11-17 years with early-onset psychosis. They found reduced odor identification ability with 46% of the patient population scoring within the hyposmic range. Olfactory dysfunction was associated with the expression of negative symptoms (Corcoran et al. 2005) . The test results were compared with previously published normative data. Although this study shows reduced olfactory function in patients with early onset of psychosis, further research is needed to confirm these findings.
One cross-sectional study including 30 children between aged 6 and 12 years examined the relation between olfaction and aggression in children with a history of childhood maltreatment (Dileo et al. 2017 ). Although they did not find an association between olfactory function and aggression in their population, children in the study group performed worse than those of a control group on an odor identification test (Dileo et al. 2017) . The authors suggest altered or reduced neuronal development within the orbito-frontal cortex in children with a history of childhood maltreatment causing the lower odor identification ability (Dileo et al. 2017) .
The diseases grouped in the category of psychiatric diseases are heterogeneous as are the described effects on olfactory function. Although the influence of eating disorders on olfactory function remains unclear, the current literature on olfactory function in patients with ADHD points to a superior olfactory function in these patients. Only 1 study examined the olfactory function in patients with early onset of psychosis and aggression, respectively. The findings in the current literature are sufficient to conclude reduced olfactory function in patients with autism spectrum disorders. The changes in olfactory function, increase or decrease, are explained by the authors due to altered neuronal processing in disease-specific areas, such as the orbito-frontal cortex, the amygdala, or prefrontal cortex, which are all related to processing of olfactory information (Gottfried 2006) .
Environmental factors and toxins
This category includes 4 cross-sectional studies observing the effect of environmental factors and toxins on olfactory function in children, including prenatal exposure to alcohol (Bower et al. 2013 ), second-hand smoking (Nageris et al. 2001) , and manganese exposure (Lucchini et al. 2012; Iannilli et al. 2016) . Olfactory function was measured using an odor identification test in all 4 studies. Bower et al. (2013) studied 16 children aged 6-16 years after heavy prenatal alcohol exposure. These children performed worse on an odor identification test compared with an age-matched control group. The authors explain the reduced odor identification ability with a neurotoxic effect of prenatal alcohol exposure (Bower et al. 2013) . Since no cognitive testing was performed, it is unknown whether the olfactory dysfunction resulted from isolated toxic damage to olfactory structures or to general neurodevelopmental alterations in brain structures, or both. Nageris et al. (2001) observed reduced olfactory function in children aged 10-15 years, who are exposed to passive smoking compared to a non-exposed control group (Nageris et al. 2001) . A total of 10 children of parents who smoke at least 1 pack of cigarettes per day were included in this cross-sectional study. The authors explain that smoking and passive smoking can cause damage to the olfactory epithelium and the olfactory receptor neurons and therefore leads to reduced olfactory function (Nageris et al. 2001 ).
In 2 cross-sectional studies, the effect of manganese exposure in Italian children was examined (Lucchini et al. 2012; Iannilli et al. 2016) . Lucchini et al. (2012) described reduced odor identification ability in 143 children aged 11-14 years who were exposed to manganese in comparison to a non-exposed control group (n = 157). Olfactory function was negatively correlated with the environmental manganese concentration measured in the soil (Lucchini et al. 2012) . Central odor processing was measured in a subgroup of the study population by means of functional magnetic resonance imaging (MRI) (Iannilli et al. 2016) . Although this subgroup (n = 4) did not differ in odor identification score compared to a control group (n = 10), an altered central odor processing in the manganeseexposed group was observed. The difference regarding odor identification scores between these studies is explained by the small sample size in the second study (Lucchini et al. 2012; Iannilli et al. 2016) . In both studies, the altered olfactory function and changed central processing of odors are explained by the neurotoxic effect of manganese (Lucchini et al. 2012; Iannilli et al. 2016) .
Although only 4 studies are reported in the current literature addressing the effect of environmental factors and toxins, the vulnerability of the olfactory system toward environmental factors or toxins becomes obvious. The underlying pathophysiology was not examined in the 4 studies. According to the authors, different mechanisms, depending on the environmental factor or toxin, could be involved-from damaging of the olfactory epithelium by passive smoking, changed neuronal processing caused by prenatal alcohol exposure or a neurotoxic effect of manganese (Nageris et al. 2001; Lucchini et al. 2012; Bower et al. 2013; Iannilli et al. 2016) .
Other diseases
This category summarizes publications that did not fit in one of the 5 categories described above.
Obrebowski et al. (2000) showed, in a cross-sectional study of 30 children aged 10-16 years, that children with higher BMI had a superior olfactory sensitivity toward odors such as lemon, mint, or coffee (Obrebowski et al. 2000) . The BMI of the children was not reported and the underlying mechanisms are not clarified (Obrebowski et al. 2000) . Niedzielska et al. (2000) observed reduced olfactory sensitivity in children with allergies (Niedzielska et al. 2000) . Olfactory sensitivity of 33 children aged 5-16 years with different allergies was compared with a control group of 36 healthy children. The patient group was heterogeneous with some children suffering from other diseases, for example, bronchial asthma, making a clear association between allergies and altered olfactory sensitivity difficult (Niedzielska et al. 2000) . The authors explain the reduced olfactory sensitivity with inflammation of the olfactory mucosa (Niedzielska et al. 2000) .
In a case report, a 10-year-old boy, who suffered from anosmia after herpetic meningoencephalitis, was described (Landis et al. 2010 ). The child was followed up over a period of 4 years. During that time, olfactory function, especially odor identification ability, increased and the child scored within hyposmic range. MRI showed extensive damage of the left anterior temporal lobe and parts of the left anterior hippocampus, which was discussed to have caused the olfactory dysfunction (Landis et al. 2010) .
In an Australian pilot study of 20 children aged 5-18 years with chronic kidney disease, the odor identification ability was not altered compared with healthy control children (Armstrong et al. 2010 ). In addition, no correlation between kidney function by means of glomerular filtration rate and olfactory function could be observed (Armstrong et al. 2010) .
Discussion
This review gives an overview about the diseases and environmental factors that might influence olfactory function in children and adolescents and may lead to an acquired olfactory dysfunction in this age group. For a summary, see Table 1 . The literature covers a wide range of diseases, which mainly cause a reduction in olfactory function. Only a few studies report an increase in olfactory function, for example, ADHD or obesity (Obrebowski et al. 2000; Romanos et al. 2008; Schecklmann et al. 2011; Lorenzen et al. 2016) . Therefore, it can be concluded that acquired olfactory dysfunction is present in children. The youngest children examined were 4 years of age (Rothschild et al. 1995; Schriever et al. 2014) . It cannot be ruled out that children younger than 4 years do not exhibit acquired olfactory dysfunction but reliable olfactory testing in children younger than 5 years of age is challenging (Cavazzana et al. 2017 ).
The influence of certain diseases on olfactory function in children is better understood than in others. All studies about the influence of TBI on the sense of smell reported a reduction in olfactory function (Roberts and Simcox 1996; Sandford et al. 2006; Swann et al. 2006; Schriever et al. 2014; Bakker et al. 2016a Bakker et al. , 2016b . Sufficient literature also describes reduced olfactory function in children with adenoid hypertrophy (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) . In addition, consistent findings are reported in literature about reduced olfactory function in association with autism spectrum disorders (Bennetto et al. 2007; Dudova et al. 2011; May et al. 2011; Parma et al. 2014; Kumazaki et al. 2016; Muratori et al. 2017) . Based on these findings, children and adolescents with adenoid hypertrophy, autism spectrum disorders, and after TBI are at risk of developing olfactory dysfunction and olfactory testing should be performed in these patient populations. The relation between other diseases and olfactory function still remains unclear. This is especially true for most psychiatric diseases such as eating disorders or ADHD (Roessner et al. 2005; Karsz et al. 2008; Romanos et al. 2008; Schecklmann et al. 2011; Ghanizadeh et al. 2012; Schecklmann et al. 2012; Stein et al. 2012; Lorenzen et al. 2016) .
Attempts have been made to classify acquired olfactory dysfunction according to the location of the presumed pathology ). According to the anatomical location of the lesion, 3 categories have been identified: 1) conductive dysfunction: resulting from blockage of odorant transmission to the olfactory neuroepithelium; 2) sensorineural dysfunction: resulting from damage or loss of the olfactory neuroepithelium or nerve; and 3) central dysfunction: resulting from damage or loss of the olfactory processing pathways of the central nervous system . Not all described causes of acquired olfactory dysfunction in children can be easily assigned to one of the 3 categories and an overlap in mechanisms resulting in olfactory dysfunction can be observed. Nevertheless, based on the presented data of authors' explanation, we made the attempt to assign the 3 classifications to the causes of olfactory function in children and adolescents (Table 2) .
Conductive dysfunction
Adenoid hypertrophy increases the resistance in the upper airways and therefore reduces the airflow to the olfactory cleft. Due to the reduced airflow to the olfactory cleft, viewer odor molecules are transported to the olfactory epithelium resulting in a reduced olfactory function (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014) . The finding that olfactory function is restored after surgical adenoidectomy supports this thesis. Due to a reduced airflow in the nasal cavity, the reduced olfactory function in patients with tracheotomy can be classified as a conductive dysfunction (Rothschild et al. 1995; Kennedy et al. 2016 ).
Sensorineural dysfunction
Several diseases or events can cause damage to the olfactory receptor neurons leading to a sensorineural olfactory dysfunction. Allergic rhinitis, systemic allergies, and adenoid hypertrophy are associated with recurrent or chronic inflammation of the nasal and olfactory mucosa leading to damage of olfactory receptor neurons (Niedzielska et al. 2000; Konstantinidis et al. 2005; Tansuker et al. 2014; Kutlug et al. 2016) . Although, in the same classification, the mechanism underlying olfactory dysfunction after TBI is different. Transection or shearing of the olfactory fila as they transverse the cribriform plate is thought to be one reason for olfactory dysfunction secondary to TBI (Delank and Fechner 1996; Roberts and Simcox 1996; Sandford et al. 2006; Swann et al. 2006; Schriever et al. 2014; Bakker et al. 2016a ). Chemotherapy as a potent cell toxin might cause temporary sensorineural olfactory dysfunction (Cohen et al. 2012) . Although, to a lesser degree, second-hand smoking might also affect olfactory function by damaging olfactory receptor neurons (Nageris et al. 2001) . Roessner et al. (2005) described the reduced olfactory sensitivity in patients with anorexia nervosa to be caused by a sensorineural dysfunction. This statement is only based on olfactory testing. Further research is necessary to confirm this finding.
Central dysfunction
A variety of diseases and factors are described in the literature to cause reduced olfactory function due to central dysfunction. Intracranial hemorrhage or edema may lead to dysfunction of the central structures involved in olfactory processing (Roberts and Simcox 1996; Sandford et al. 2006; Schriever et al. 2014; Lötsch et al. 2015; Bakker et al. 2016a) . It is likely that the altered olfactory function in association with diseases grouped in the category "psychiatric diseases" is due to changes in central processing (Schecklmann et al. 2013) . The anatomical and functional overlap of brain areas involved in olfactory processing (Gottfried 2006 ) and disease-specific alterations in central nervous functions such as orbito-frontal cortex (Bennetto et al. 2007; Karsz et al. 2008; Lorenzen et al. 2016) , amygdala (Schecklmann et al. 2012; Kumazaki et al. 2016) , and temporal lobe (Schecklmann et al. 2011 ) might explain this close association between olfactory function and psychiatric diseases in children and adolescents. Neurotoxins by means of environmental exposure to manganese might lead to central olfactory dysfunction, which was shown not only in olfactory testing but also by changed neuronal processing of olfactory information (Lucchini et al. 2012; Iannilli et al. 2016 ). In addition, infections of the central nervous system might cause damage in brain areas associated with olfactory processing and therefore leading to central olfactory dysfunction (Landis et al. 2010) .
Although a total of 44 publications target the issue of olfactory function in children, we are only beginning to understand this issue. Based on the literature, there is already evidence for clinical implications of olfactory testing. Olfactory dysfunction is thought to be a marker for frontal brain damage after TBI and therefore might serve to better understand the neurological outcome after TBI (Varney 1988; Roberts and Simcox 1996) . Olfactory function in children with adenoid hypertrophy is reduced and significantly improved after surgical therapy (Ghorbanian et al. 1983; Delank 1992; Konstantinidis et al. 2005; Altundag et al. 2014 ). Research in adults has shown that olfactory dysfunction can drastically influence everyday life of patients and even lead to depression (Croy and Hummel 2017) . If olfactory dysfunction would be diagnosed early in childhood, an adequate therapy could be initiated. Depending on the etiology, causal therapy is available for olfactory dysfunction, for example, due to adenoid hypertrophy. In addition, the "olfactory training" has proven to be effective in adults (Konstantinidis et al. 2013; Langdon et al. 2018 ) and a promising study in healthy children has also shown an improvement of olfactory function (Mori et al. 2015) . If not treatable, children and their parents could be educated about olfactory dysfunction to prevent negative implications of a reduced sense of smell. This review provides information for the clinician in which diseases olfactory function might be changed and therefore olfactory testing should be considered.
Further research is needed to address this issue, to specify the influence of the above-mentioned diseases on olfactory function in children, and to examine the influence of other disease on the sense of smell in this age group.
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